Cytochrome P450-3A phenotyping using midazolam is not altered by OATP1B1 polymorphisms.

MLA

Ziesenitz, V. C., et al. “Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms.” Clinical Pharmacology and Therapeutics, vol. 93, no. 5, May 2013, p. 388. EBSCOhost, https://doi.org/10.1038/clpt.2013.46.

APA

Ziesenitz, V. C., Weiss, J., Haefeli, W. E., & Mikus, G. (2013). Cytochrome P450-3A phenotyping using midazolam is not altered by OATP1B1 polymorphisms. Clinical Pharmacology and Therapeutics, 93(5), 388. https://doi.org/10.1038/clpt.2013.46

Chicago

Ziesenitz, V C, J Weiss, W E Haefeli, and G Mikus. 2013. “Cytochrome P450-3A Phenotyping Using Midazolam Is Not Altered by OATP1B1 Polymorphisms.” Clinical Pharmacology and Therapeutics 93 (5): 388. doi:10.1038/clpt.2013.46.